Roche Pipeline Report
A report from FierceBiotech:
Roche provides update on leading late-stage pharmaceutical pipeline
New data on medicines with the potential to redefine standard of care highlighted at Investor event
Posted December 9, 2010
"Roche (SIX: RO, ROG; OTCQX: RHHBY) today will provide an update on its leading late-stage pipeline comprising twelve new molecular entities in key therapeutic areas. The London investor event will focus on major progress that has been achieved in recent months with Roche's late-stage pipeline assets in the areas of oncology and CNS, as well as on further development plans of these potential breakthrough medicines."
read the full report
Roche provides update on leading late-stage pharmaceutical pipeline
New data on medicines with the potential to redefine standard of care highlighted at Investor event
Posted December 9, 2010
"Roche (SIX: RO, ROG; OTCQX: RHHBY) today will provide an update on its leading late-stage pipeline comprising twelve new molecular entities in key therapeutic areas. The London investor event will focus on major progress that has been achieved in recent months with Roche's late-stage pipeline assets in the areas of oncology and CNS, as well as on further development plans of these potential breakthrough medicines."
read the full report
posted by Anthony Risser at 2:37 PM
0 Comments:
Post a Comment
<< Home